The association between patient age and prostate cancer stage and grade at diagnosis

BJU International

Volumn 94, Issue 3, 2004, Pages 303-306

  Alibhai, Shabbir M H ^a,b,c   Krahn, Murray D ^a,c,d   Fleshner, Neil E ^c   Cohen, Marsha M ^b,c   Tomlinson, George A ^a,c,d   Naglie, Gary ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aged; Grade; Neoplasm staging; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANADA; CANCER GRADING; CANCER REGISTRY; CANCER STAGING; CHI SQUARE TEST; GROUPS BY AGE; HUMAN; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVIEW; TRANSURETHRAL RESECTION; TUMOR BIOPSY;

ADULT; AGE FACTORS; AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 4344570233     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.04883.x     Document Type: Review

References (26)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15-36
2. Krongrad A, Lai H, Lai S. Variation in prostate cancer survival explained by significant prognostic factors. J Urol 1997; 158: 1487-90
3. Montironi R. Prognostic factors in prostate cancer. BMJ 2001; 322: 378-9
4. Walsh PC. The natural history of localized prostate cancer: A guide to therapy. In Walsh PC, Retik AB, Vaughan ED, Wein AJ eds. Campbell's Urology, 7th edn. Philadelphia: WB Saunders Co, 1998: 2539-46
5. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995; 274: 626-31
6. Goodwin JS, Samet JM, Key CR, Humble C, Kutvirt D, Hunt C. Stage at diagnosis of cancer varies with the age of the patient. J Am Geriatr Soc 1986; 34: 20-6
7. Yancik R, Ries LA. Cancer in older persons. Magnitude of the problem - how do we apply what we know? Cancer 1994; 74: 1995-2003
8. Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, Severson RK. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973-87. Urology 1995; 45: 93-101
9. Mettlin G, Murphy GP, Cunningham MP, Menck HR. The national cancer data base report on race, age, and region variations in prostate cancer treatment. Cancer 1997; 80: 1261-6
10. Smedley HM, Sinnott M, Freedman LS, Macaskill P, Naylor CPE, Pillers EMK. Age and survival in prostatic carcinoma. Br J Urol 1983; 55: 529-33
11. Borek D, Butcher D, Hassanein K, Holmes F. Relationship of age to histologic grade in prostate cancer. Prostate 1990; 16: 305-11
12. Smith DS, Catalona WJ, Herschman JD. Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA 1996; 276: 1309-15
13. Carter HB, Epstein JI, Chan DW, Fozard JL, Pearson JD. Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer. JAMA 1997; 277: 1456-60
14. Holowaty EJ, Moravan V, Lee G, Chong N, Dale D. A reabstraction study to estimate the completeness and accuracy of data elements in the Ontario Cancer Registry. Report submitted to Health Canada, 27 February 1996.
15. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 5th edition. New York: Wiley-Liss, 1997
16. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58-64
17. Goodman CM, Busuttil A, Chisholm GD. Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate. Br J Urol 1988; 62: 576-80
18. Richie JP, Catalona WJ, Ahmann FR et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology 1993; 42: 365-74
19. Ganz PA. Age and gender as factors in cancer therapy. Clin Geriatr Med 1993; 9: 145-55
20. Fowler FJ Jr, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000; 283: 3217-22
21. Ramsey EW, Elhilali M, Goldenberg SL et al. Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. J Urol 2000; 163: 499-502
22. Hankey BF, Feuer EJ, Clegg LX et al. Cancer surveillance series: interpreting trends in prostate cancer - part I. evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999; 91: 1017-24
23. Epstein JI, Walsh PC, Carter HB. Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease. J Urol 2001; 166: 1688-91
24. Holmes FF, Hearne EI. Cancer stage-to-age relationship: implications for cancer screening in the elderly. J Am Geriatr Soc 1981; 29: 55-7
25. Mor V, Masterson-Allen S, Goldberg RJ, Cummings FJ, Glicksman AS, Fretwell MD. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc 1985; 33: 585-9
26. Bickell NA, Chassin MR. Determining the quality of breast cancer care: do tumor registries measure up? Ann Intern Med 2000; 132: 705-10